126 related articles for article (PubMed ID: 31845585)
21. Assessment of cholesterol homeostasis in the living human brain.
Haider A; Zhao C; Wang L; Xiao Z; Rong J; Xia X; Chen Z; Pfister SK; Mast N; Yutuc E; Chen J; Li Y; Shao T; Warnock GI; Dawoud A; Connors TR; Oakley DH; Wei H; Wang J; Zheng Z; Xu H; Davenport AT; Daunais JB; Van RS; Shao Y; Wang Y; Zhang MR; Gebhard C; Pikuleva I; Levey AI; Griffiths WJ; Liang SH
Sci Transl Med; 2022 Oct; 14(665):eadc9967. PubMed ID: 36197966
[TBL] [Abstract][Full Text] [Related]
22. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms.
Alavi MS; Karimi G; Ghanimi HA; Roohbakhsh A
Eur J Pharmacol; 2023 Jun; 949():175726. PubMed ID: 37062503
[TBL] [Abstract][Full Text] [Related]
23. Molecular Basis of the Recognition of Cholesterol by Cytochrome P450 46A1 along the Major Access Tunnel.
Shi N; Zheng Q; Zhang H
ACS Chem Neurosci; 2022 May; 13(10):1526-1533. PubMed ID: 35438962
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.
Han M; Wang S; Yang N; Wang X; Zhao W; Saed HS; Daubon T; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
EMBO Mol Med; 2020 Jan; 12(1):e10924. PubMed ID: 31777202
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of oral turinabol by the human brain cholesterol 24-hydroxylase CYP46A1.
Putkaradze N; Hartz P; Hutter MC; Zapp J; Thevis M; Bernhardt R
J Steroid Biochem Mol Biol; 2021 Sep; 212():105927. PubMed ID: 34089835
[TBL] [Abstract][Full Text] [Related]
26. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain.
Mast N; White MA; Bjorkhem I; Johnson EF; Stout CD; Pikuleva IA
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9546-51. PubMed ID: 18621681
[TBL] [Abstract][Full Text] [Related]
27. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.
Pikuleva IA; Cartier N
Front Aging Neurosci; 2021; 13():696778. PubMed ID: 34305573
[TBL] [Abstract][Full Text] [Related]
29. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
31. The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj
El-Darzi N; Mast N; Li Y; Dailey B; Kang M; Rhee DJ; Pikuleva IA
Cell Mol Life Sci; 2023 Jul; 80(7):194. PubMed ID: 37392222
[TBL] [Abstract][Full Text] [Related]
32. In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine.
Mast N; Linger M; Clark M; Wiseman J; Stout CD; Pikuleva IA
Mol Pharmacol; 2012 Nov; 82(5):824-34. PubMed ID: 22859721
[TBL] [Abstract][Full Text] [Related]
33. Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development.
Ahmed H; Wang Y; Griffiths WJ; Levey AI; Pikuleva I; Liang SH; Haider A
Brain; 2024 May; 147(5):1622-1635. PubMed ID: 38301270
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.
Mast N; Charvet C; Pikuleva IA; Stout CD
J Biol Chem; 2010 Oct; 285(41):31783-95. PubMed ID: 20667828
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis.
Tsitsou-Kampeli A; Suzzi S; Kenigsbuch M; Satomi A; Strobelt R; Singer O; Feldmesser E; Purnapatre M; Colaiuta SP; David E; Cahalon L; Hahn O; Wyss-Coray T; Shaul Y; Amit I; Schwartz M
Cell Rep Med; 2023 Nov; 4(11):101278. PubMed ID: 37944529
[TBL] [Abstract][Full Text] [Related]
36. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
[TBL] [Abstract][Full Text] [Related]
37. Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.
Saadane A; Mast N; Trichonas G; Chakraborty D; Hammer S; Busik JV; Grant MB; Pikuleva IA
Am J Pathol; 2019 Feb; 189(2):405-425. PubMed ID: 30448403
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
[TBL] [Abstract][Full Text] [Related]
39. Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).
Uto Y
Expert Opin Ther Pat; 2015 Mar; 25(3):373-7. PubMed ID: 25514969
[TBL] [Abstract][Full Text] [Related]
40. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
